Dr. Stepanians, a biostatistician and founder of PROMETRIKA, has been selected to co-chair the BSDMCT Working Group of MassBio. In her two-year tenure as co-chair, Dr. Stepanians and her colleagues will develop industry-relevant programs and bring subject matter experts to MassBio’s forums covering the industry’s most timely topics.
Dr. Stepanians holds an MS in Mathematics (Statistics) from MIT and a PhD in Statistics from BU. In her 30 year career, Dr. Stepanians has been active in clinical trial design, data management systems development, and statistical analysis of clinical trial data. She has managed the statistical analyses of many NDA filings in varying indications and regularly represents sponsors at FDA meetings. In addition to her current responsibilities as PROMETRIKA’s President and CEO, Dr. Stepanians is actively involved in project work for PROMETRIKA’s clients. She provides trial design and statistical analysis consulting and sits on Independent Data Monitoring Boards (IDMBs). Prior to founding PROMETRIKA, Dr. Stepanians was Director of Biostatistics and Data Management at Muro Pharmaceuticals.